AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 165 filers reported holding AKERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $192,721 | +25.5% | 3,810,194 | +15.8% | 0.03% | +33.3% |
| Q2 2023 | $153,595 | +53.0% | 3,289,643 | +25.4% | 0.02% | +40.0% |
| Q1 2023 | $100,383 | -23.7% | 2,623,680 | +9.3% | 0.02% | -28.6% |
| Q4 2022 | $131,577 | -99.7% | 2,401,037 | +64.2% | 0.02% | +162.5% |
| Q3 2022 | $49,797,000 | +1057.3% | 1,462,424 | +221.2% | 0.01% | +700.0% |
| Q2 2022 | $4,303,000 | -33.4% | 455,302 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $6,462,000 | -73.7% | 455,364 | -60.7% | 0.00% | -50.0% |
| Q4 2021 | $24,524,000 | -4.7% | 1,159,530 | +0.7% | 0.00% | 0.0% |
| Q3 2021 | $25,738,000 | -10.1% | 1,151,599 | -0.2% | 0.00% | -33.3% |
| Q2 2021 | $28,636,000 | +10.5% | 1,154,203 | +29.2% | 0.00% | 0.0% |
| Q1 2021 | $25,910,000 | +52.8% | 893,146 | +35.8% | 0.00% | +50.0% |
| Q4 2020 | $16,962,000 | +9.6% | 657,455 | +30.8% | 0.00% | 0.0% |
| Q3 2020 | $15,471,000 | +323.6% | 502,481 | +242.9% | 0.00% | – |
| Q2 2020 | $3,652,000 | -28.1% | 146,532 | -38.8% | 0.00% | -100.0% |
| Q1 2020 | $5,077,000 | +1.0% | 239,478 | +5.8% | 0.00% | 0.0% |
| Q4 2019 | $5,025,000 | +8.3% | 226,399 | +11.0% | 0.00% | 0.0% |
| Q3 2019 | $4,639,000 | +20.2% | 203,913 | +1.2% | 0.00% | 0.0% |
| Q2 2019 | $3,859,000 | – | 201,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |